FDA-Cleared Medical Device Distribution Business

Full Editorial Writeup

This is a distributor of FDA-cleared medical devices positioned at the intersection of clinical technology and supply chain. The listing markets it as a scalable, high-margin platform, and the one hard number that matters is $13.56M in EBITDA against a $70M asking price, a 5.16x multiple. Revenue, margins, founding year, and location are all undisclosed, which is a real problem for a deal of this size.

What we can infer: a business generating this level of EBITDA in FDA-regulated medical device distribution has clearance, contracts, and a functioning supply chain, all of which carry meaningful barriers to entry. Distribution of clinical devices is a recurring, non-discretionary category because hospitals and clinics buy the equipment and consumables regardless of the macro cycle. The FDA clearance itself is an asset that a new entrant cannot replicate quickly.

The headline is thin on substance and heavy on adjectives like "advanced enterprise intelligence," which usually signals a broker dressing up a solid but ordinary distributor. For a buyer with capital, the opportunity is real but the diligence burden is large: you are underwriting an eight-figure check against a listing that discloses almost nothing beyond a single EBITDA line and a growth-positioning reason for sale.